Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Period
Forecast Period
Six straight quarters of gains. That's the headline for Fusidic Acid, with Germany sitting at the sharp end of it, up by 6.9% in the first half of 2026 (H1 2026) alone, from a value of USD 258/KG in Q1 to USD 276/KG in Q2. Two forces did most of the work. The fermentation capacity that simply hasn't kept pace with the orders. And a pickup in the demand for the topical and systemic staphylococcal treatments that shows no sign of slowing. Globally the move was gentler but still real, from a value of USD 225.2/KG to USD 240.7/KG, also a gain of 6.9 percent. For the second half of 2026 (H2 2026), a global band of USD 240-265/KG looks reasonable, with the fermentation supply staying tight and the procurement teams keeping locking in volume ahead of need.
Start with the biology behind it. Fusidic Acid comes out of a fermentation process using the fungus Fusidium coccineum, then gets extracted, purified, and crystallised to the pharmaceutical grade. Mechanistically, it blocks the bacterial protein synthesis by binding the elongation factor G and stopping the elongation step cold. That gives it a real bacteriostatic bite against the gram-positive organisms, staphylococci in particular. Where does the volume actually go? Mostly into the topical and dermatological products, creams and ointments treating the skin and soft tissue infections. The systemic tablets and parenteral formulations for the more serious staphylococcal cases pull a smaller but meaningful share. The ophthalmic preparations round things out. On the cost side, the fermentation yield sets the floor. The regulatory compliance layers on top of that. How fast the pharmaceutical demand recovers determines everything in between.
The setup heading into the second half of 2026 (H2 2026) looks tight, not loose. The formulators spent the H1 leaning on a strategic procurement, buying ahead of need rather than trusting the spot market, which tells you something about how nervous the fermentation capacity picture has made people. The regulatory compliance costs kept climbing everywhere, not just in one region, its own signal that this isn't just a localized squeeze.
Two scenarios worth watching. If the fermentation capacity tightens further, or a major facility goes down unexpectedly, the prices could break above the band entirely. If the demand softens or new capacity comes online faster than expected, the opposite happens, and the buying eases below it.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 240 - 265 | Fermentation capacity and pharmaceutical demand support |
| United States | 245 - 270 | Regulatory compliance costs maintain firm pricing |
| China | 225 - 248 | Fermentation capacity keeps China most affordable |
| Germany | 270 - 298 | Compliance and quality standards support premium |
| India | 230 - 253 | Export-oriented production supports firm middle |
The regulatory compliance costs kept grinding higher in the US through the Q2, and that alone explains most of the move from a value of USD 235/KG to USD 251/KG, a jump of 6.8 percent. The dermatological and systemic formulation demand stayed steady, not surging, suggesting the price increase is more of a cost story than a demand story.
Why did the price of Fusidic Acid change in Q2 2026 in the United States?
Regulatory compliance and testing requirements kept pushing landed costs up. Demand from dermatological and systemic antibiotic formulators held steady, keeping the market engaged without adding new upward pressure of its own. Fermentation capacity constraints at supplying facilities layered on the rest, taking the market to USD 251/KG.
China is still the cheapest market on the entire list, though at a value of USD 220/KG the gap to everyone else is narrowing. The quarterly rise of 6.8 percent came almost entirely from the tight fermentation capacity, not a demand spike.
Why did the price of Fusidic Acid change in Q2 2026 in China?
Fermentation capacity stayed tight at key production facilities, really the whole story this quarter. Renewed pharmaceutical demand for topical and systemic formulations added some pull on top. Domestic capacity is still large enough to keep China the cheapest option despite the increase.
Germany led every single tracked market this quarter, and it wasn't close. A value of USD 276/KG, up by 6.9% from Q1. The strict quality and compliance standards explain the persistent premium, with a renewed dermatological demand pushing things further still.
Why did the price of Fusidic Acid change in Q2 2026 in Germany?
Strict European quality and compliance standards kept pushing production expenses higher. Renewed dermatological and systemic formulation demand added real pull on top of that. Between the two, the market landed at USD 276/KG.
India climbed by 6.9% to a value of USD 233/KG, roughly in line with the global pace. The export-oriented pharmaceutical demand kept growing through the quarter, with the fermentation processing costs firming right alongside, a fairly clean two-factor story.
Why did the price of Fusidic Acid change in Q2 2026 in India?
Export-oriented pharmaceutical demand kept growing, meaning steady pull on supply all quarter. Fermentation processing costs firmed in step with broader input cost inflation across the sector. Domestic formulation demand rounded things out near USD 233/KG.
A strategic procurement was the theme in the US during the Q1, with the buyers positioning ahead of the expected fermentation tightness rather than waiting for the spot market to move. The prices rose by 4.4% from Q4 2025, landing at a value of USD 235/KG.
Why did the price of Fusidic Acid change in Q1 2026 in the United States?
Strategic procurement activity ahead of anticipated capacity constraints drove most of the buying interest this quarter. Regulatory compliance costs firmed steadily on top of that. USD 235/KG was where things settled.
China's Q1 average came in at a value of USD 206/KG, up by about 4.0% from Q4. The export demand from pharmaceutical formulators stayed steady, with the fermentation costs firming in parallel, nothing dramatic but a clear upward drift.
Why did the price of Fusidic Acid change in Q1 2026 in China?
Export demand from pharmaceutical formulators held steady through the quarter. Fermentation processing costs firmed at the same time, pushing the floor up modestly. USD 206/KG is where the quarter landed.
Germany advanced by 4.5% from Q4 2025 to a value of USD 258/KG in Q1 2026. The pharmaceutical demand recovery was the main driver, with the firming compliance costs adding a smaller but real contribution.
Why did the price of Fusidic Acid change in Q1 2026 in Germany?
Pharmaceutical demand recovery lifted procurement across dermatological formulators through the quarter. Firming regulatory compliance costs added further pressure on European production. The combination set the stage for the stronger move that followed in Q2.
India moved up by 4.3% from Q4 2025 to a value of USD 218/KG in Q1 2026, driven by the growing export-oriented demand, with the firming fermentation processing costs alongside, the same two-factor pattern that would carry through into the Q2.
Why did the price of Fusidic Acid change in Q1 2026 in India?
Export-oriented pharmaceutical demand kept growing through the quarter. Fermentation processing costs firmed in response to broader input pressures. That combination paved the way for the bigger increase in Q2.
What stands out across these six quarters is the consistency of it. Every single one closed higher than the last. That's unusual for a specialty pharmaceutical intermediate, pointing to a structural supply issue rather than just a temporary blip. From a value of USD 190.7/KG in Q1 2025 to USD 240.7/KG by Q2 2026, a cumulative gain of 26.2 percent. The fermentation capacity utilisation and the strategic procurement activity, with the buyers front-running the expected shortages, explain nearly all of it.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 240.7 | +6.9% | ↑ Rising |
| Q1 2026 | 225.2 | +4.3% | ↑ Rising |
| Q4 2025 | 216.0 | +4.3% | ↑ Rising |
| Q3 2025 | 207.1 | +4.4% | ↑ Rising |
| Q2 2025 | 198.3 | +4.0% | ↑ Rising |
| Q1 2025 | 190.7 | - | - Stable |
Every quarter of the year 2025 closed higher than the one before it for Fusidic Acid. From a value of USD 190.7/KG in Q1 to USD 216.0/KG by Q4, a climb of 13.3 percent over the year. The underlying cause barely changed from quarter to quarter, the fermentation capacity constraints across the major producing hubs, with a genuinely renewed demand for the staphylococcal infection treatments alongside, rather than any single event or shock.
The US prices climbed by 13.1% over the year, from a value of USD 199/KG to USD 225/KG. The regulatory compliance costs did most of the lifting. The steady dermatological demand added a consistent support underneath.
China went from a value of USD 175/KG to USD 198/KG, also 13.1 percent. Two things drove it. The fermentation capacity kept tightening as the year went on. The export demand grew right alongside it.
Germany posted the largest gain of all four tracked regions at 13.3 percent, from a value of USD 218/KG to USD 247/KG. The strict compliance standards were the constant here. A renewed dermatological demand provided extra lift.
India rose from a value of USD 184/KG to USD 209/KG, a gain of 13.6 percent. The highest percentage move of any region tracked. The export-oriented pharmaceutical demand was the clear driver throughout.
Expert Market Research: Your Source for Real-Time Fusidic Acid Price Intelligence
Expert Market Research tracks the Fusidic Acid prices continuously, across every major producing and consuming region, with the focus staying on the why, not just the what. The team traces the causation through the fermentation yield and processing economics, the regulatory compliance cost cycles, and the shifting dermatological and systemic pharmaceutical demand. Contact Expert Market Research today for the Fusidic Acid pricing data, a bespoke market analysis, and a strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
The topical and dermatological formulations account for the largest share of the demand globally, treating the skin and soft tissue infections through creams and ointments. The systemic tablets and parenteral products for the serious staphylococcal infections, with the ophthalmic preparations for eye infections alongside, make up the rest.
As of the Q2 2026, the prices stood at a value of USD 251/KG in the United States, USD 220/KG in China, USD 276/KG in Germany, and USD 233/KG in India. Germany's compliance and quality standards keep it at the top of that range by a clear margin.
The global prices moved from a value of USD 216.0/KG in Q4 2025 to USD 225.2/KG in Q1 2026, then on to USD 240.7/KG by Q2, a gain of 6.9 percent across the half-year. The tightening fermentation capacity. The steady strategic procurement activity. Between the two of them, they drove essentially all of it.
The fermentation capacity utilisation stayed genuinely tight across every single major producing region, not just one. The pharmaceutical formulators shifted noticeably toward a strategic procurement over the spot buying, a sign of real supply concern rather than routine restocking. A renewed demand for the staphylococcal treatments added to an already tight picture.
A global range of USD 240 to 265/KG looks reasonable for the rest of the year 2026, assuming the fermentation constraints persist and the pharmaceutical demand keeps its current pace.
Germany sits the highest, owing to the strict compliance and quality standards. The United States and India occupy the middle ground, shaped by the regulatory costs and the export-oriented production respectively. China remains the cheapest, thanks to its scale of domestic fermentation capacity.
Monthly. Reach out to the Expert Market Research team directly for real-time pricing intelligence.
The fermentation yield and processing costs matter the most, with the regulatory compliance and testing expenses close behind. The dermatological and systemic pharmaceutical demand cycles play a role too, and any capacity constraint at a major facility can move the whole market quickly.
China and India lead on the fermentation capacity, with the European producers holding the specialised pharmaceutical-grade facilities. A change in the fermentation yield anywhere, or a shift in the dermatological demand, tends to show up across every single regional market within a quarter or two.
The quarterly trends help time the dermatological and systemic formulation contracts around the fermentation capacity cycles specifically. Watching the fermentation yield and processing costs gives an early read on where the production floor is heading, which matters more here than in most commodity markets given how tight the capacity has stayed.
Basic Report -
One Time
Basic Report -
Annual Subscription
Detailed Report -
One Time
Detailed Report -
Annual Subscription
Basic Report -
One Time
USD 799
tax inclusive*
Basic Report -
Annual Subscription
USD 3,499
tax inclusive*
Detailed Report -
One Time
USD 4,299
tax inclusive*
Detailed Report -
Annual Subscription
USD 7,999
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.